Elizabeth Bhatt - 21 Jul 2021 Form 4 Insider Report for Applied Molecular Transport Inc.

Role: Chief Bus. & Strategy Officer
Signature: /s/ Brandon Hants Attorney-in-Fact for Elizabeth Bhatt
Issuer symbol: N/A
Transactions as of: 21 Jul 2021
Net transactions value: -$288,607
Form type: 4
Filing time: 22 Jul 2021, 19:59:48 UTC
Next filing: 27 Aug 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AMTI	Common Stock	Options Exercise	$41,490	+9,000		$4.61^*	9,000	21 Jul 2021	Direct
transaction	AMTI	Common Stock	Sale	$241,762	-6,640	-74%	$36.41^*	2,360	21 Jul 2021	Direct	F1
transaction	AMTI	Common Stock	Sale	$88,335	-2,360	-100%	$37.43^*	0	21 Jul 2021	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	AMTI	Stock Option (Right to Buy)	Options Exercise	$0	-9,000	-3%	$0.000000	292,632	21 Jul 2021	Common Stock	9,000	$4.61	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in column is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.00 to $36.99, inclusive. The reporting person undertakes to provide Applied Molecular Transport, Inc., any security holder of Applied Molecular Transport, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2	The price reported in column is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.27 to $37.61, inclusive. The reporting person undertakes to provide Applied Molecular Transport, Inc., any security holder of Applied Molecular Transport, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3	1/4th of the shares subject to the option became vested on the Exercise Date and 1/48th of the shares subject to the option vest monthly thereafter, provided that the reporting person is a service provider to the issuer on each such vest date.